|
Mahamaya Lifesciences Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
280.39 Cr.
|
P/BV
|
4.74
|
Book Value (Rs.)
|
25.27
|
|
52 Week High/Low (Rs.)
|
122/111
|
FV/ML
|
10/1200
|
P/E(X)
|
21.66
|
|
Bookclosure
|
|
EPS (Rs.)
|
5.53
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 83.01 |
| Total Income From Operations | 83.01 |
| | |
| EXPENDITURE | |
| Consumption of Raw Materials | 68.85 |
| Increase/Decrease in Stocks | 0.71 |
| Employees Cost | 1.96 |
| Depreciation | 0.54 |
| Other Expenses | 4.33 |
| Total Expenses | 76.39 |
| | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 6.62 |
| Other Income | 1.03 |
| P/L Before Interest, Excpt. Items & Tax | 7.65 |
| Interest | 1.96 |
| P/L Before Exceptional Items & Tax | 5.69 |
| P/L Before Tax | 5.69 |
| Tax | 1.59 |
| P/L After Tax from Ordinary Activities | 4.10 |
| Net Profit/Loss For the Period | 4.10 |
| Net P/L After Minority Interest & Share Of Associates | 4.10 |
| | |
| Equity Share Capital | 17.77 |
| EPS Before Extra Ordinary * | |
| Basic EPS (Rs.) | 2.31 |
| Diluted EPS (Rs.) | 2.31 |
| EPS After Extra Ordinary * | |
| Basic EPS (Rs.) | 2.31 |
| Diluted EPS (Rs.) | 2.31 |
| | |
| PBITOE Margin (%) | 7.97 |
| PBTE Margin (%) | 6.85 |
| PBT Margin (%) | 6.85 |
| PAT Margin (%) | 4.94 |
| PAT After MI And SOA Margin (%) | 4.94 |
